{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:16:47Z","timestamp":1777576607987,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:00:00Z","timestamp":1663027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:00:00Z","timestamp":1663027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Yu Lei","award":["82073800"],"award-info":[{"award-number":["82073800"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Chimeric antigen receptor T-cell (CAR-T) therapy is a new and efficient cellular immunotherapy. The therapy shows significant efficacy, but also has serious side effects, collectively known as cytokine release syndrome (CRS). At present, some CRS-related cytokines and their roles in CAR-T therapy have been confirmed by experimental studies. However, the mechanism of CRS remains to be fully understood.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Based on big data for human protein interactions and meta-learning graph neural network, we employed known CRS-related cytokines to comprehensively investigate the CRS associated cytokines in CAR-T therapy through protein interactions. Subsequently, the clinical data for 119 patients who received CAR-T therapy were examined to validate our prediction results. Finally, we systematically explored the roles of the predicted cytokines in CRS occurrence by protein interaction network analysis, functional enrichment analysis, and pathway crosstalk analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified some novel cytokines that would play important roles in biological process of CRS, and investigated the biological mechanism of CRS from the perspective of functional analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>128 cytokines and related molecules had been found to be closely related to CRS in CAR-T therapy, where several important ones such as IL6, IFN-\u03b3, TNF-\u03b1, ICAM-1, VCAM-1 and VEGFA were highlighted, which can be the key factors to predict CRS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12859-022-04917-2","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T08:09:48Z","timestamp":1663056588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Investigation of CRS-associated cytokines in CAR-T therapy with meta-GNN and pathway crosstalk"],"prefix":"10.1186","volume":"23","author":[{"given":"Zhenyu","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengkui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqing","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weixing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,13]]},"reference":[{"issue":"5","key":"4917_CR1","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s11684-019-0714-8","volume":"13","author":"H Chen","year":"2019","unstructured":"Chen H, Wang F, Zhang P, Zhang Y, Chen Y, Fan X, Cao X, Liu J, Yang Y, Wang B, et al. Management of cytokine release syndrome related to CAR-T cell therapy. Front Med. 2019;13(5):610\u20137.","journal-title":"Front Med"},{"key":"4917_CR2","first-page":"56","volume":"15","author":"S Wong","year":"2018","unstructured":"Wong S. Review of the development of CAR_T therapy techniques. Technol Innov. 2018;15:56\u20139.","journal-title":"Technol Innov"},{"issue":"5","key":"4917_CR3","doi-asserted-by":"publisher","first-page":"e026644","DOI":"10.1136\/bmjopen-2018-026644","volume":"9","author":"ML Schubert","year":"2019","unstructured":"Schubert ML, Schmitt A, Sellner L, Neuber B, Kunz J, Wuchter P, Kunz A, Gern U, Michels B, Hofmann S, et al. Treatment of patients with relapsed or refractory CD19+ lymphoid disease with T lymphocytes transduced by RV-SFG.CD19.CD28.4\u20131BBzeta retroviral vector: a unicentre phase I\/II clinical trial protocol. BMJ Open. 2019;9(5):e026644.","journal-title":"BMJ Open"},{"issue":"3","key":"4917_CR4","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/bjh.15195","volume":"181","author":"S Li","year":"2018","unstructured":"Li S, Zhang J, Wang M, Fu G, Li Y, Pei L, Xiong Z, Qin D, Zhang R, Tian X, et al. Treatment of acute lymphoblastic leukaemia with the second generation of CD19 CAR-T containing either CD28 or 4\u20131BB. Br J Haematol. 2018;181(3):360\u201371.","journal-title":"Br J Haematol"},{"issue":"1","key":"4917_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrclinonc.2017.148","volume":"15","author":"SS Neelapu","year":"2018","unstructured":"Neelapu SS, Tummala S, Kebriaei P, Wierda W, Gutierrez C, Locke FL, Komanduri KV, Lin Y, Jain N, Daver N, et al. Chimeric antigen receptor T-cell therapy - assessment and management of toxicities. Nat Rev Clin Oncol. 2018;15(1):47\u201362.","journal-title":"Nat Rev Clin Oncol"},{"issue":"S1","key":"4917_CR6","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1002\/ajh.25445","volume":"94","author":"AV Hirayama","year":"2019","unstructured":"Hirayama AV, Turtle CJ. Toxicities of CD19 CAR-T cell immunotherapy. Am J Hematol. 2019;94(S1):S42\u20139.","journal-title":"Am J Hematol"},{"issue":"26","key":"4917_CR7","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1182\/blood-2016-04-703751","volume":"127","author":"JN Brudno","year":"2016","unstructured":"Brudno JN, Kochenderfer JN. Toxicities of chimeric antigen receptor T cells: recognition and management. Blood. 2016;127(26):3321\u201330.","journal-title":"Blood"},{"issue":"6","key":"4917_CR8","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1158\/2159-8290.CD-16-0040","volume":"6","author":"DT Teachey","year":"2016","unstructured":"Teachey DT, Lacey SF, Shaw PA, Melenhorst JJ, Maude SL, Frey N, Pequignot E, Gonzalez VE, Chen F, Finklestein J, et al. Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia. Cancer Discov. 2016;6(6):664\u201379.","journal-title":"Cancer Discov"},{"issue":"6","key":"4917_CR9","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41591-018-0041-7","volume":"24","author":"T Giavridis","year":"2018","unstructured":"Giavridis T, van der Stegen SJC, Eyquem J, Hamieh M, Piersigilli A, Sadelain M. CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade. Nat Med. 2018;24(6):731\u20138.","journal-title":"Nat Med"},{"issue":"21","key":"4917_CR10","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1182\/blood-2017-06-793141","volume":"130","author":"KA Hay","year":"2017","unstructured":"Hay KA, Hanafi LA, Li D, Gust J, Liles WC, Wurfel MM, Lopez JA, Chen J, Chung D, Harju-Baker S, et al. Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy. Blood. 2017;130(21):2295\u2013306.","journal-title":"Blood"},{"key":"4917_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1109\/TNNLS.2020.2978386","volume":"32","author":"Z Wu","year":"2020","unstructured":"Wu Zonghan, Pan Shirui, Chen Fengwen, Long Guodong, Zhang Chengqi, and Yu Philip S. A comprehensive survey on graph neural networks. IEEE Trans Neural Netw Learn Syst. 2020;32(1):4\u201324.","journal-title":"IEEE Trans Neural Netw Learn Syst"},{"key":"4917_CR12","doi-asserted-by":"crossref","unstructured":"Li Q, Han H, Wu X-M. Deeper insights into graph convolutional networks for semi-supervised learning. Assoc Adv Artif Intell 2018.","DOI":"10.1609\/aaai.v32i1.11604"},{"key":"4917_CR13","doi-asserted-by":"crossref","unstructured":"Zhou F, Cao C, Zhang K, Trajcevski G, Zhong T, Geng J. Meta-GNN on few-shot node classification in graph. In: ASONAM 2019.","DOI":"10.1145\/3357384.3358106"},{"key":"4917_CR14","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C. XGBoost: a scalable tree boosting system. In: Proceedings of the 22nd ACM SIGKDD international conference on knowledge discovery and data mining. 2016; 785\u2013794.","DOI":"10.1145\/2939672.2939785"},{"issue":"1","key":"4917_CR15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W da Huang","year":"2009","unstructured":"da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44\u201357.","journal-title":"Nat Protoc"},{"issue":"1","key":"4917_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"W da Huang","year":"2009","unstructured":"da Huang W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37(1):1\u201313.","journal-title":"Nucleic Acids Res"},{"issue":"23","key":"4917_CR17","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. 2020;383(23):2255\u201373.","journal-title":"N Engl J Med"},{"issue":"5","key":"4917_CR18","first-page":"601","volume":"37","author":"ZY Cheng","year":"2010","unstructured":"Cheng ZY. Cytokine receptor-JAK kinase signaling pathway and myeloproliferative disease. Cancer Prev Treat Res. 2010;37(5):601\u20135.","journal-title":"Cancer Prev Treat Res"},{"key":"4917_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jneuroim.2007.05.011","volume":"188","author":"D Rosenkranz","year":"2007","unstructured":"Rosenkranz D, Weyer S, Tolosa E, Gaenslen A, Berg D, Leyhe T, Gasser T, Stoltze L. Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration. J Neuroimmunol. 2007;188:117\u201327.","journal-title":"J Neuroimmunol"},{"issue":"FI1","key":"4917_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ehjcr\/ytaa179","volume":"4","author":"ZD Demertzis","year":"2020","unstructured":"Demertzis ZD, Dagher C, Malette KM, Fadel RA, Bradley PB, Brar I, Rabbani BT, Suleyman G. Cardiac sequelae of novel coronavirus disease 2019 (COVID-19): a clinical case series. Eur Heart J Case Rep. 2020;4(FI1):1\u20136.","journal-title":"Eur Heart J Case Rep"},{"issue":"20","key":"4917_CR21","first-page":"2212","volume":"133","author":"P Karschnia","year":"2019","unstructured":"Karschnia P, Jordan JT, Forst DA, et al. Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells. Blood. 2019;133(20):2212\u201321.","journal-title":"Blood J Am Soc Hematol"},{"issue":"5","key":"4917_CR22","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00281-017-0639-8","volume":"39","author":"BG Chousterman","year":"2017","unstructured":"Chousterman BG, Swirski FK, Weber GF. Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol. 2017;39(5):517\u201328.","journal-title":"Semin Immunopathol"},{"issue":"419","key":"4917_CR23","first-page":"1","volume":"9","author":"G Esp\u00edgol-Frigol\u00e9","year":"2017","unstructured":"Espigol-Frigole G, Planas-Rigol E, Ohnuki H, Salvucci O, Kwak H, Ravichandran S, Luke B, Cid MC, Tosato G. Identification of IL-23p19 as an endothelial proinflammatory peptide that promotes gp130-STAT3 signaling. Sci Signal. 2016;9:ra28.","journal-title":"Sci Signal"},{"issue":"3","key":"4917_CR24","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/bjh.15644","volume":"183","author":"KA Hay","year":"2018","unstructured":"Hay KA. Cytokine release syndrome and neurotoxicity after CD19 chimeric antigen receptor-modified (CAR-) T cell therapy. Br J Haematol. 2018;183(3):364\u201374.","journal-title":"Br J Haematol"},{"issue":"2","key":"4917_CR25","first-page":"303","volume":"31","author":"L Jingjing","year":"2011","unstructured":"Jingjing L. Methods of studying the interaction between cytokines and membrane receptor proteins. Chem Life. 2011;31(2):303\u20137.","journal-title":"Chem Life"},{"issue":"7","key":"4917_CR26","first-page":"3192","volume":"37","author":"K Wei","year":"2018","unstructured":"Wei K. Pathogenesis of Alzheimer\u2019s disease based on pathway crosstalk analysis. Genomics Appl Biol. 2018;37(7):3192\u20139.","journal-title":"Genomics Appl Biol"},{"issue":"5","key":"4917_CR27","doi-asserted-by":"publisher","first-page":"e0127438","DOI":"10.1371\/journal.pone.0127438","volume":"10","author":"M Liu","year":"2015","unstructured":"Liu M, Fan R, Liu X, Cheng F, Wang J. Pathways and networks-based analysis of candidate genes associated with nicotine addiction. PLoS One. 2015;10(5):e0127438.","journal-title":"PLoS One"},{"issue":"6","key":"4917_CR28","doi-asserted-by":"publisher","first-page":"4452","DOI":"10.1007\/s12035-016-9998-8","volume":"54","author":"Y Hu","year":"2017","unstructured":"Hu Y, Pan Z, Hu Y, et al. Network and pathway-based analyses of genes associated with Parkinson's disease. Mol Neurobiol. 2017;54:4452\u201365.","journal-title":"Mol Neurobiol"},{"key":"4917_CR29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40364-018-0116-0","volume":"6","author":"Z Wang","year":"2018","unstructured":"Wang Z, Han W. Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy. Biomark Res. 2018;6:4.","journal-title":"Biomark Res"},{"key":"4917_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.blre.2018.11.002","volume":"34","author":"J Brudno","year":"2019","unstructured":"Brudno JN, Kochenderfer JN. Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and management. Blood Rev. 2019;34:45\u201355.","journal-title":"Blood Rev"},{"key":"4917_CR31","doi-asserted-by":"publisher","first-page":"623610","DOI":"10.3389\/fimmu.2021.623610","volume":"12","author":"Y Chen","year":"2021","unstructured":"Chen Y, Li R, Shang S, Yang X, Li L, Wang W, Wang Y. Therapeutic potential of TNFalpha and IL1beta blockade for CRS\/ICANS in CAR-T therapy via ameliorating endothelial activation. Front Immunol. 2021;12:623610.","journal-title":"Front Immunol"},{"issue":"6","key":"4917_CR32","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/his.13728","volume":"73","author":"T Miyata-Takata","year":"2018","unstructured":"Miyata-Takata T, Chuang S, Takata K, Toji T, Maeda Y, Sato Y, Yoshino T. Expression of T-cell receptor signalling pathway components in extranodal NK\/T-cell lymphoma. Histopathology. 2018;73(6):1030\u20138.","journal-title":"Histopathology"},{"issue":"5","key":"4917_CR33","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","volume":"77","author":"S Banerjee","year":"2017","unstructured":"Banerjee S, Biehl A, Gadina M, Hasni S, Schwartz DM. JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects. Drugs. 2017;77(5):521\u201346.","journal-title":"Drugs"},{"issue":"5\u20136","key":"4917_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/1759720X18776224","volume":"10","author":"CJ Malemud","year":"2018","unstructured":"Malemud CJ. The role of the JAK\/STAT signal pathway in rheumatoid arthritis. Ther Adv Musculoskelet Dis. 2018;10(5\u20136):117\u201327.","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"8","key":"4917_CR35","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.tips.2020.06.007","volume":"41","author":"W Luo","year":"2020","unstructured":"Luo W, Li YX, Jiang LJ, Chen Q, Wang T, Ye DW. Targeting JAK-STAT signaling to control cytokine release syndrome in COVID-19. Trends Pharmacol Sci. 2020;41(8):531\u201343.","journal-title":"Trends Pharmacol Sci"},{"key":"4917_CR36","doi-asserted-by":"publisher","DOI":"10.1242\/dev.156018","author":"N Anthoney","year":"2018","unstructured":"Anthoney N, Foldi I, Hidalgo A. Toll and Toll-like receptor signalling in development. Development. 2018. https:\/\/doi.org\/10.1242\/dev.156018.","journal-title":"Development"},{"issue":"6","key":"4917_CR37","doi-asserted-by":"publisher","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6):a001651.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"5","key":"4917_CR38","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.molmed.2016.03.002","volume":"22","author":"G Cildir","year":"2016","unstructured":"Cildir G, Low K, Tergaonkar V. Noncanonical NF-\u03baB Signaling in Health and Disease. Trends Mol Med. 2016;22(5):414\u201329.","journal-title":"Trends Mol Med"},{"issue":"8","key":"4917_CR39","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/ni.2065","volume":"12","author":"A Oeckinghaus","year":"2011","unstructured":"Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-kappaB signaling pathways. Nat Immunol. 2011;12(8):695\u2013708.","journal-title":"Nat Immunol"},{"issue":"3","key":"4917_CR40","first-page":"1997","volume":"19","author":"YJ Guo","year":"2020","unstructured":"Guo YJ, Pan WW, Liu SB, Shen ZF, Xu Y, Hu LL. ERK\/MAPK signalling pathway and tumorigenesis. Exp Ther Med. 2020;19(3):1997\u20132007.","journal-title":"Exp Ther Med"},{"issue":"34","key":"4917_CR41","doi-asserted-by":"publisher","first-page":"8102","DOI":"10.1523\/JNEUROSCI.0473-17.2017","volume":"37","author":"SR Hutton","year":"2017","unstructured":"Hutton SR, Otis JM, Kim EM, Lamsal Y, Stuber GD, Snider WD. ERK\/MAPK signaling is required for pathway-specific striatal motor functions. J Neurosci. 2017;37(34):8102\u201315.","journal-title":"J Neurosci"},{"issue":"6","key":"4917_CR42","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1172\/JCI126397","volume":"129","author":"AD Cohen","year":"2019","unstructured":"Cohen AD, Garfall AL, Stadtmauer EA, Melenhorst JJ, Lacey SF, Lancaster E, Vogl DT, Weiss BM, Dengel K, Nelson A, et al. B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma. J Clin Invest. 2019;129(6):2210\u201321.","journal-title":"J Clin Invest"},{"issue":"8","key":"4917_CR43","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1161\/ATVBAHA.118.311150","volume":"38","author":"EJ Folco","year":"2018","unstructured":"Folco EJ, Mawson TL, Vromman A, Bernardes-Souza B, Franck G, Persson O, Nakamura M, Newton G, Luscinskas FW, Libby P. Neutrophil extracellular traps induce endothelial cell activation and tissue factor production through interleukin-1alpha and cathepsin G. Arterioscler Thromb Vasc Biol. 2018;38(8):1901\u201312.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"4917_CR44","first-page":"1602","volume":"5","author":"P Xia","year":"2015","unstructured":"Xia P, Xu XY. PI3K Akt mTOR signaling pathway in cancer stem cells from basic research to clinical application. Am J Cancer Res. 2015;5(5):1602\u20139.","journal-title":"Am J Cancer Res"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-022-04917-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-022-04917-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-022-04917-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T08:10:10Z","timestamp":1663056610000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-022-04917-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,13]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4917"],"URL":"https:\/\/doi.org\/10.1186\/s12859-022-04917-2","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,13]]},"assertion":[{"value":"15 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethic Committee of First People's Hospital Affiliated to Soochow University. We have received informed consents from individual patients who have participated in this study. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"373"}}